SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
四叶草
Lv1
20 积分
2022-09-14 加入
最近求助
最近应助
互助留言
Cost-Effectiveness Analysis of Durvalumab Plus Chemotherapy in the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer
1小时前
已完结
Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non–Small Cell Lung Cancer in the Context of the US Health Care System
1天前
已完结
Cost-Effectiveness of Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
1天前
已完结
Cancer-Related Lymphedema and Psychological Distress
4天前
已完结
Patient-perceived dysphagia and voice change post thyroid surgery: a telephone questionnaire
4个月前
已完结
Voice Changes Without Laryngeal Nerve Alterations After Thyroidectomy: The Need For Prospective Trials - A Review Study
4个月前
已完结
在美国,Alpelisib 联合氟维司群治疗 PIK3CA 突变、HR+/HER2- 晚期乳腺癌是否具有成本效益?
8个月前
已完结
Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the United States
8个月前
已完结
The cost-effectiveness analysis of maintenance olaparib plus Bevacizumab in patients with advanced ovarian cancer: based on the final survival results from PAOLA-1 trial
8个月前
已完结
Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2- Metastatic Breast Cancer in Postmenopausal Women in the USA
8个月前
已完结
没有进行任何应助
帮大忙了
1小时前
速度真快
1天前
速度真快
1天前
帮大忙了
8个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论